ReviewFrontiers in immunologyPublished
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Review
- Venue
- Frontiers in immunology
- Published
- Subject terms
- Humans; Biological Products; Risk Assessment; Europe; Drug Development; Immunogenicity; Bioanalysis; Biotherapeutics; Anti-drug Antibody; Immunogenicity Mitigation; Immunogenicity Monitoring; Immunogenicity Risk Assessment
- PubMed ID
- 40475758
- PubMed Central ID
- PMC12138202
- Open access
- Yes, open
- Added to directory
- Source checked